2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$164.78+$3.16 (+1.95%)
Price as of Jun 23, 2026 5:12 PM EDT- $16.3BMarket Cap
- 28.47%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$164.78+$3.16 (+1.95%)
Earnings Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 18.33% | ||
12-Month Momentum | 22.22% | ||
3-Month Risk Adjusted Momentum | 128.01% | ||
12-Month Risk Adjusted Momentum | 74.21% |
True Yield
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.54% | ||
Net Debt Paydown Yield | 1.01% |
Financial Health Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 10 |